International validation of the revised European Organisation for Research and treatment of cancer head and neck cancer module, the EORTC QLQ-HN43

Autor: Singer, Susanne, Amdal, Cecilie Delphin, Hammerlid, Eva, Tomaszewska, Iwona M, Castro Silva, Joaquim, Mehanna, Hisham, Santos, Marcos, Inhestern, Johanna, Brannan, Christine, Yarom, Noam, Fullerton, Amy, Pinto, Monica, Arraras, Juan I, Kiyota, Naomi, Bonomo, Pierluigi, Sherman, Allen C, Baumann, Ingo, Galalae, Razvan, Fernandez Gonzalez, Loreto, Nicolatou-Galitis, Ourania, Abdel-Hafeez, Zeinab, Raber-Durlacher, Judith, Schmalz, Claudia, Zotti, Paola, Boehm, Andreas, Hofmeister, Dirk, Krejovic Trivic, Sanja, Loo, Suat, Chie, Wei-Chu, Bjordal, Kristin, Brokstad Herlofson, Bente, Grégoire, Vincent, Licitra, Lisa, EORTC Quality of Life and the EORTC Head and Neck Cancer Groups
Přispěvatelé: Oral Medicine, Maxillofacial Surgery (AMC), Oral and Maxillofacial Surgery, UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Service de radiothérapie oncologique
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Multimodal therapies
Quality of life
Male
medicine.medical_specialty
SDG 16 - Peace
Psychometrics
Intraclass correlation
Medizin
Sensitivity and Specificity
03 medical and health sciences
0302 clinical medicine
Cronbach's alpha
Surveys and Questionnaires
Validation
Outcome Assessment
Health Care

medicine
Humans
Prospective Studies
030212 general & internal medicine
Head and neck cancer
Reliability (statistics)
Aged
Aged
80 and over

business.industry
SDG 16 - Peace
Justice and Strong Institutions

Discriminant validity
Reproducibility of Results
Cancer
Middle Aged
medicine.disease
Combined Modality Therapy
Confirmatory factor analysis
humanities
Justice and Strong Institutions
3. Good health
Europe
Chemoradiation
Otorhinolaryngology
Head and Neck Neoplasms
030220 oncology & carcinogenesis
Quality of Life
Physical therapy
Female
business
Zdroj: on behalf of the EORTC Quality of Life and the EORTC Head and Neck Cancer Groups 2019, ' International validation of the revised European Organisation for Research and treatment of cancer head and neck cancer module, the EORTC QLQ-HN43 : Phase IV ', Head and Neck, vol. 41, no. 6, pp. 1725-1737 . https://doi.org/10.1002/hed.25609
Head and Neck, 41(6), 1725-1737. John Wiley and Sons Inc.
Head & neck, 41(6), 1725-1737. John Wiley and Sons Inc.
Head & neck, Vol. 41, no.6, p. 1725-1737 (2019)
ISSN: 1043-3074
DOI: 10.1002/hed.25609
Popis: Background: We validated the new European Organisation for Research and Treatment of Cancer Quality of Life Head and Neck Module (EORTC QLQ-HN43). Methods: We enrolled 812 patients with head and neck cancer from 18 countries. Group 1 completed the questionnaire before therapy, and 3 and 6 months later. In group 2 (survivors), we determined test–retest reliability using intraclass correlation coefficients (ICC). Internal consistency was assessed using Cronbach's Alpha, the scale structure with confirmatory factor analysis, and discriminant validity with known-group comparisons. Results: Cronbach's alpha was >0.70 in 10 of the 12 multi-item scales. All standardized factor loadings exceeded 0.40. The ICC was >0.70 in all but two scales. Differences in scale scores between known-groups were >10 points in 17 of the 19 scales. Sensitivity to change was found to be sufficient in 18 scales. Conclusions: Evidence supports the reliability and validity of the EORTC QLQ-HN43 as a measure of quality of life.
Databáze: OpenAIRE